Basavaradhya S. Shruthi

Persistent inflammation during anti-tuberculosis treatment with diabetes comorbidity

Nathella Pavan Kumar, Kiyoshi F. Fukutani, Basavaradhya S. Shruthi et al. · eLife · 2019 · 64 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Plasma chemokines are biomarkers of disease severity, higher bacterial burden and delayed sputum culture conversion in pulmonary tuberculosis

Nathella Pavan Kumar, Kadar Moideen, Arul Nancy et al. · Scientific Reports · 2019 · 63 citations · Full text

Public Health, Immunology, Infectious Diseases +15

Elevated levels of matrix metalloproteinases reflect severity and extent of disease in tuberculosis-diabetes co-morbidity and are predominantly reversed following standard anti-tuberculosis or metformin treatment

Nathella Pavan Kumar, Kadar Moideen, Vijay Viswanathan et al. · BMC Infectious Diseases · 2018 · 44 citations · Full text

Medicine, Internal Medicine, Pathology +13

Plasma Eicosanoid Levels in Tuberculosis and Tuberculosis-Diabetes Co-morbidity Are Associated With Lung Pathology and Bacterial Burden

Nathella Pavan Kumar, Kadar Moideen, Arul Nancy et al. · Frontiers in Cellular and Infection Microbiology · 2019 · 36 citations · Full text

Veterinary Medicine, Immunology, Pathobiology +15

Syndrome Evaluation System (SES) versus Blood Culture (BACTEC) in the Diagnosis and Management of Neonatal Sepsis - A Randomized Controlled Trial

B. Vishnu Bhat, P. Prasad, Venkata Banda Ravi Kumar et al. · The Indian Journal of Pediatrics · 2016 · 33 citations

Medicine, Pediatrics, Neonatal Health +15